 Mä oon täällä mukaan aikaa, miten löydä eri hieman hieman hieman hieman hieman. Joten mitä hieman hieman hieman hieman? Se ei ole hieman, se on hieman. Hieman, mitä hieman hieman on? Se on omaa, se on omaa, että omaa. When you get sick, they try to treat you. The problem with this strategy is that it is immensely expensive. If you look only type 2 diabetes and cardiovascular diseases, the combined costs of these two diseases are 1.3 trillion every year. It's the combined cross domestic product of Finland, Sweden and Singapore. It's a huge problem. So what can we do? We need to change the strategy. So instead of treating sick people, we need to prevent people to get sick. We need prevention. So what does the prevention mean? How can we prevent? Many people are talking about this already. But what it really means? We need to screen people. We need to know who are in a risk of getting a chronic disease in the future. No risk to get diabetes or cardiovascular disease in 10 years. So we know what is the problem. The problem is sick care. We know what is the solution, prevention. So how to do it? So we at Nightingale have developed a blood test. We take one blood sample and from this one blood sample we can quantify more than 200 different biomarkers. How do we do this? We put the blood sample inside a high frequency magnet. What happens in the magnet, the molecules in the blood, they start to resonate. We record this resonance and then from the resonance spectra we can quantify a big number of biomarkers. What does this matter? Why this is important? It's important because these molecules, these biomarkers that we quantify, it is shown that they are predictive of type 2 diabetes and cardiovascular diseases. So we have the problem, sick care, we have the solution, prevention. And now we also have a technology, the blood test to know who are in a risk of getting a chronic disease. It's quite good but it's not enough. So the next thing is to know what to do. This is a very interesting topic because if you look what can we do, you have to look at the diseases. So let's think about type 2 diabetes. Let's think about cardiovascular disease. These are diseases that are defined by multiple factors in life. It's not only one thing that defines your risk. It's not something that you inherit. Type 2 diabetes is 95% a living habit disease. So we have to change the living habits. There is no white pill. There is no simple solution how you can make the change. You have to look at the broader picture. So we cannot tell you beforehand that okay, eat blueberries, eat salmon, life will be good. We don't know, no one knows. But what we can do is that if we detect based on our blood test, if we detect that you are in a risk of getting a chronic disease, getting type 2 diabetes in 10 years, we can follow up what happens. So let's assume you start eating differently. You start exercising more. So today how do you know if it's really working? How do you know? Well, you don't. You can look the mirror. You can look the scale. Maybe something happens. Usually it's very difficult. But what happens with the molecules? We can see if the molecules in your blood are responding the changes that you do with your living habits. So what you can actually do, you can learn your own body. So now we are starting to have the pieces together. So we can actually detect if you have a risk. We know how to do interventions. So exercise, diet. And then we also know if the interventions that you are doing, we know if they are working. So that's it. This is how you can actually do preventative healthcare. I've been talking about this for some years already when building Nightingale as a company. And the question always is like, okay, it sounds fantastic, but can you really do it? Is it really possible? So actually yesterday we announced this technology available for the first time for the consumers here in Slush. So the service is called VETA 360. It's actually, the boot is there. If you go there straight and turn right, it's available. You can have it. And what we provide to you, we provide you the future risk of getting a chronic disease. This is extremely important for Nightingale. It's about changing the entire primary care system. Changing it from sick care to prevention. This is also something that it started, for us it started as a small idea in a small cafe. Today we are a team of 70 people. We have raised more than 40 million euros. So we are building our dream. And the first step in this dream is available today here in Slush. Thank you.